Business Context and Reporting Period
This Form 8-K was filed by Atlantic Technology Ventures, Inc. on December 6, 2001. The report discloses a material event regarding a private placement of common stock. Note: The request metadata references "TG THERAPEUTICS, INC.", but the filing text explicitly identifies the registrant as Atlantic Technology Ventures, Inc.
Key Financial Metrics
- Capital Raised: Approximately $2,000,000 (minimum aggregate subscription amount).
- Share Price: $0.24 per share.
- Maximum Potential Raise: Up to $3,000,000 (subject to additional commitments).
- Use of Proceeds: Working capital and general corporate purposes.
- Placement Fee: 7% of the aggregate subscription amount plus 10% of the number of shares and warrants issued.
- Warrant Terms: Investors receive one warrant to purchase one share for every share purchased.
Material Changes
The primary material change is the successful closing of the initial tranche of a private placement on December 6, 2001, following commitments received on November 30, 2001. This represents a significant liquidity event for the company, though the filing does not provide comparative financial statements or prior period metrics to quantify changes in revenue, profit, or debt levels.
Guidance, Outlook, and Risks
- Outlook: Management expects to receive additional commitments of up to $1 million to reach the maximum aggregate subscription amount.
- Risks: The filing explicitly states there can be no assurances that the additional $1 million in commitments will be secured.
- Unusual Items: The transaction includes a warrant component attached to every share sold, which may impact future dilution.
Investor Verification Checklist
- Verify the total number of shares issued in the initial $2 million closing.
- Confirm whether the additional $1 million in commitments was subsequently secured.
- Review the attached Securities Purchase Agreement (Exhibit 10.1) for specific investor rights and warrant exercise terms.
- Check subsequent filings for the actual net proceeds after deducting the 7% cash fee and the 10% warrant fee.